Vraylar Coupons & Prices

Vraylar FAQs

How much does Vraylar cost without insurance?

The price of a one-month supply of Vraylar depends on patient out-of-pocket expenses but without insurance is around $2,072.03 for 30, 1.5mg capsules. However, you can save significantly on this and other prescription drugs when you pay a discounted price from SingleCare. By using the free Vraylar coupons from the SingleCare discount program, you can pay our lowest price of $1,370.84 the next time you order a Vraylar refill of 30, 1.5mg capsules. Present your discount card to the pharmacy staff to compare Vraylar prices at a participating pharmacy near you. Eligible patients are Americans anywhere in the United States with a valid prescription—there are no application processes, household income guidelines, or service fees to use our savings.

How much does Vraylar cost with insurance?

The average copay for Vraylar depends on your health insurance plan. Check with your pharmacist to calculate your copay with insurance. Keep in mind that you could pay $1,370.84 for 30, 1.5mg capsules when you use a Vraylar coupon from SingleCare. In some instances, this may be a better option and lower cost than your out-of-pocket costs with insurance coverage. To compare costs, ask your pharmacist to run your SingleCare discount card before you pay for your Vraylar prescription.

Does Medicare cover Vraylar and how much does it cost?

Vraylar is covered by all Medicare prescription plans. Your copay, however, will depend on your particular plan, copay discounts, and coverage restrictions. Contact your pharmacist to find out your cost with insurance.

SingleCare offers an alternative to Medicare for those seeking a lower-priced option. Ask any of the participating pharmacies to find out how much you can save on your Vraylar cost using SingleCare. Our lowest price for Vraylar is currently $1,370.84 for 30, 1.5mg capsules.

Is there a generic of Vraylar?

Vraylar is a brand-name drug, and there are no generics available at this time. Vraylar contains the active ingredient cariprazine.

Who makes Vraylar? 

The pharmaceutical company that makes Vraylar is called Allergan, Inc.

What is Vraylar?

Vraylar is an FDA-approved medicine that is used once daily to treat patients with certain mental and mood disorders. This includes bipolar disorder, depression associated with bipolar disorder (bipolar depression), and schizophrenia in adults. It is also used to treat depression in adults, in combination with antidepressants. Vraylar is not approved for use in children.

Vraylar contains cariprazine, which belongs to a group of drugs known as atypical antipsychotic drugs. It works by balancing chemicals in the brain that control your mood. These chemicals are called serotonin and dopamine. 

What are the side effects of Vraylar?

Common side effects of Vraylar include dizziness, drowsiness, fatigue, nausea, constipation, indigestion, blurred vision, back pain, dry mouth, and weight gain. 

Some patients who take Vraylar experience orthostatic hypotension (a drop in blood pressure when standing) or fainting, especially with increases in dosage. Your healthcare provider will monitor you, especially if you are at risk for low blood pressure.

Certain patients experience extrapyramidal symptoms (EPS), which are movement disorders related to taking antipsychotics, including Vraylar. One form of EPS is called tardive dyskinesia, which causes facial symptoms such as grimacing, rapid eye blinking, and/or lip smacking. If you experience any movement problems, tremors, or muscle stiffness, contact your healthcare provider right away. 

Other serious adverse reactions may include low white blood cell counts, problems controlling your body temperature, high cholesterol, and high blood sugar or diabetes. 

Serious allergic reactions may occur. If you have symptoms of hives, shortness of breath, or swelling of the face, lips, tongue, or throat, get emergency medical help. 

Serious skin reactions may occur, which also require emergency medical attention. Symptoms may include fever, sore throat, burning eyes, skin pain, red or purple rash, and blistering or peeling skin. 

This is not a full list of side effects, and others may occur. Read the Vraylar medication guide for additional important information and seek medical advice from your healthcare provider before using Vraylar.

Are there interactions with Vraylar?

Before taking Vraylar, tell your health care provider about all the medications you take, including prescription drugs, over-the-counter medicines, and vitamins or supplements. Although this is not a full list, examples of drugs and substances that interact with Vraylar include:

• Alcohol

• Anticonvulsant drugs such as Dilantin (phenytoin), phenobarbital, or Tegretol (carbamazepine)

• Certain drugs used for HIV 

• MAOI drugs such as phenelzine

• Mirapex (pramipexole)

• Opioid pain medications such as oxycodone or Vicodin (hydrocodone and acetaminophen)

• Provigil (modafinil)

• Rifampin 

• St. John’s Wort

Consult your doctor for a full list of drug interactions.

How long can you stay on Vraylar? 

People who take antipsychotic medications usually need lifelong treatment. When taking Vraylar, it may take a few weeks to notice the full benefits of treatment. Your healthcare provider will guide you on Vraylar use. If you respond well to the medication and do not have any troublesome side effects, your healthcare provider may recommend long-term use for many years.

What antipsychotics are most similar to Vraylar?

Vraylar is an atypical, or second-generation, antipsychotic. Atypical antipsychotics are newer than typical (first-generation) antipsychotics and may have a lower risk of movement disorder side effects, although these effects can still occur with atypical antipsychotics. 

Examples of other drugs in the atypical antipsychotic class include:

• Abilify (aripiprazole)

• Caplyta (lumateperone)

• Geodon (ziprasidone)

• Invega (paliperidone)

• Latuda (lurasidone)

• Rexulti (brexpiprazole)

• Risperdal (risperidone)

• Seroquel (quetiapine)

• Zyprexa (olanzapine)

Your healthcare provider will prescribe the drug that is most appropriate for your condition, taking into account individual factors such as your medical history and other medications you take. 

What is the black box warning for Vraylar? 

A black box warning is the most serious warning required by the FDA. Vraylar has a black box warning, which states that the drug should not be used in elderly patients with dementia-related psychosis because it puts them at an increased risk of death. Also, antidepressants, including Vraylar, increase the risk of suicidal thoughts and behaviors in children and young adults. Patients of any age who take Vraylar must be closely monitored for changes in mood and behavior. Note: Vraylar is not approved for use in anyone under 18 years old.